![Sodium (6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(hydroxyimino)acetyl]amino]-3-[(E)-[(3…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fcas-image%2Fthumb-webp%2F313605-sodium-6r-7r-7-2z-2-5-amino-124-thiadiazol-3-yl-2-hydroxyimino-acetyl-amino-3-e-3r-1-5-methyl-2-oxo-13-dioxol-4-yl-methoxy-carbonyl-2-oxo-13-bipyrrolidin-3-ylidene-methyl-8-oxo-5-thia-1-azabicyclo-4-2-0-oct-2-ene-2-carboxylate-1-1.webp&w=3840&q=75)
CAS 252188-71-9: Sodio (6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-tiadiazol-3-il)-2-(idrossimino)acetil]amino]-3-[(E)-[(3′R)-1′-[[(5-metil-2-osso-1,3-diossol-4-il)metossi]carbonil]-2-osso[1,3′-bipirrolidin]-3-ilidene]metil]-8-osso-5-tia-1-azabiciclo[4.2.0]ott-2-ene-2-carbossilato (1:1)
Descrizione:
La sostanza chimica nota come Sodio (6R,7R)-7-[[[2Z]-2-(5-amino-1,2,4-tiadiazolo-3-il)-2-(idrossiimino)acetil]amino]-3-[(E)-[(3′R)-1′-[[(5-metil-2-oxo-1,3-diossolo-4-il)metossi]carbonil]-2-oxo[1,3′-bipirrolidina]-3-ilidene]metil]-8-oxo-5-tia-1-azabiciclo[4.2.0]ott-2-ene-2-carbossilato (1:1) è un composto organico complesso caratterizzato dalla sua struttura intricata, che include più gruppi funzionali come amino, idrossiimino e carbossilato. Questo composto presenta una struttura centrale biciclica, indicativa della sua potenziale attività biologica. La presenza di un anello di tiadiazolo suggerisce possibili proprietà antimicrobiche, mentre i gruppi oxo e diossole possono contribuire alla sua reattività e stabilità. Essendo un sale di sodio, è probabile che sia solubile in acqua, il che può migliorare la sua biodisponibilità per applicazioni farmaceutiche. La stereochimica specifica del composto, denotata dalla configurazione (6R,7R), può influenzare la sua interazione con obiettivi biologici, rendendolo un argomento di interesse in chimica medicinale e sviluppo di farmaci. In generale, questa sostanza esemplifica la complessità e la diversità dei composti organici sintetici moderni utilizzati in contesti terapeutici.
Formula:C26H26N8O11S2·Na
InChI:InChI=1S/C26H26N8O11S2.Na/c1-10-14(45-26(41)44-10)8-43-25(40)32-4-3-13(7-32)33-5-2-11(20(33)36)6-12-9-46-22-16(21(37)34(22)17(12)23(38)39)28-19(35)15(30-42)18-29-24(27)47-31-18;/h6,13,16,22,42H,2-5,7-9H2,1H3,(H,28,35)(H,38,39)(H2,27,29,31);/b11-6+,30-15-;/t13-,16-,22-;/m1./s1
InChI key:InChIKey=BYUIXTXYXHAECA-LCJFHXTKSA-N
SMILES:C(O)(=O)C=1N2[C@@]([C@H](NC(/C(=N\O)/C=3N=C(N)SN3)=O)C2=O)(SCC1/C=C\4/C(=O)N(CC4)[C@H]5CN(C(OCC=6OC(=O)OC6C)=O)CC5)[H].[Na]
Sinonimi:- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(hydroxyimino)acetyl]amino]-3-[(E)-[(3′R)-1′-[[(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy]carbonyl]-2-oxo[1,3′-bipyrrolidin]-3-ylidene]methyl]-8-oxo-, sodium salt (1:1), (6R,7R)-
- Ro 65-5788
- Sodium (6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(hydroxyimino)acetyl]amino]-3-[(E)-[(3′R)-1′-[[(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy]carbonyl]-2-oxo[1,3′-bipyrrolidin]-3-ylidene]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (1:1)
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-(5-amino-1,2,4-thiadiazol-3-yl)(hydroxyimino)acetyl]amino]-3-[(E)-[(3′R)-1′-[[(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy]carbonyl]-2-oxo[1,3′-bipyrrolidin]-3-ylidene]methyl]-8-oxo-, monosodium salt, (6R,7R)-
- Sodium (6R,7R)-3-((E)-(1-((R)-1-(((5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy)carbonyl)pyrrolidin-3-yl)-2-oxopyrrolidin-3-ylidene)methyl)-7-((Z)-2-(5-amin
- BAL 5788
- Ceftobiprole medocaril sodium
- Ceftobiprole Medocaril Sodium Sterile Powder
Ordinare per
2 prodotti.
Ceftobiprole medocaril sodium
CAS:Ceftobiprole medocaril sodium is a broad-spectrum cephalosporin antibiotic, which is a synthetically derived prodrug of ceftobiprole. Upon administration, ceftobiprole medocaril is rapidly converted into its active form, ceftobiprole, by the body's endogenous esterases. The mode of action involves binding to penicillin-binding proteins (PBPs) in the bacterial cell wall, leading to the inhibition of cell wall synthesis and ultimately the death of the bacteria. This action is effective against a wide range of gram-positive and gram-negative bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and penicillin-resistant Streptococcus pneumoniae. Ceftobiprole medocaril sodium is primarily used in the treatment of complex skin and soft tissue infections, as well as community-acquired and hospital-acquired pneumonia. Its broad-spectrum efficacy makes it a critical tool in environments where multi-drug resistant bacterial strains are prevalent. The development of ceftobiprole medocaril was driven by the urgent need for effective antibiotics against resistant pathogens, enabling it to play a vital role in modern infectious disease management and antimicrobial stewardship.Formula:C26H26N8O11S2NaPurezza:Min. 95%Peso molecolare:713.65 g/molCeftobiprole medocaril sodium
CAS:Ceftobiprole medocaril sodium (BAL5788) is a prodrug of broad-spectrum cephalosporin active against MRSA, VRSA, and resistant streptococci.Formula:C26H25N8NaO11S2Colore e forma:SolidPeso molecolare:712.64
